United States: Making Sense Of MACRA

Bracing for the Medicare Part B Overhaul: Pick a Path, Pick a Pace

The countdown has begun for the momentous Part B payment reforms created by the Medicare Access and Chip Reauthorization Act of 2015 (MACRA). On October 14, 2016, CMS released a final rule explaining, in nearly 2,400 pages, how its new Quality Payment Program, established under MACRA, will work when the first performance period goes live on January 1, 2017.

Through MACRA, Congress finally compromised and repealed the much-maligned sustainable growth rate (SGR) formula for Part B payments. While this aspect of the "doc fix" bill was widely publicized and easily understood, the other details of MACRA still remain a mystery to many. Recent surveys reveal that as of September, almost 30 percent of physicians had not even heard of MACRA, down from 50 percent in July.

The complexities of MACRA's massive overhaul of Part B pose challenges to clinicians seeking to understand and prepare for its implementation. This concern was a common theme in the more than 4,000 comments CMS received on its proposed rule. CMS responded by outlining a staged approach to implementing MACRA reform in its final rule, calling CY 2017 (and perhaps CY 2018) a "transition year." But the agency's ultimate vision is ambitious and accelerates its transition to value-based accountable care.

Immediate Impacts: Out with the Old

The SGR is out, replaced by modest annual inflationary increases of 0.5 percent until 2019 and 0.25 percent starting in 2026. MACRA also sunsets three legacy quality reporting and performance programs: (1) the Physician Quality Reporting System (PQRS), (2) the Value-based Payment Modifier (VM) and (3) the Medicare EHR Incentive Program (commonly known as the "Meaningful Use" program). The legacy programs will officially end with their final payment adjustments in 2018 based on pre-sunset reporting periods.

In With the New: What is the Medicare Quality Payment Program?

The Medicare Quality Payment Program is not just a payment rule, it is a bold "milestone" effort to transform how care is delivered and to encourage Part B clinicians to transition from fee-for-service reimbursement to alternative payment models (APMs). The Quality Payment Program offers two paths: (1) the Merit-based Incentive Payment System (MIPS) and (2) Advanced Alternative Payment Models (Advanced APMs).

Through the Quality Payment Program, CMS is encouraging clinicians to accept risk for a defined episode of care or population through participation in the Advanced APMs with a 5 percent annual incentive payment. MIPS is the default pathway for clinicians who do not qualify to participate in an Advanced APM. Failure to participate in either an Advanced APM or the MIPS results in negative payment adjustments.

Who Must Participate?

Eligible clinicians include physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and groups that bill under Medicare Part B. Clinicians may elect to participate individually or as a group with a common tax identification number.

There are certain limited exclusions for:

  • Low Volume Clinicians: Clinicians with less than $30,000 in Medicare Part B allowed charges or 100 or fewer Medicare patients. CMS anticipates approximately 32.5 percent of eligible clinicians billing Part B services will qualify as low-volume clinicians in CY 2017.
  • New Medicare Enrolled Eligible Clinicians: New Medicare enrolled practitioners in their first year.

Picking a Path

Option 1:Advanced APMs

To participate in the Advanced APM pathway, clinicians must have a certain percentage of their patients or payments through an Advanced APM. The final rule describes the criteria for an APM to qualify as an Advanced APM.

  • As a threshold matter, the APM must be: an incentive model under Section 1115A of the Social Security Act (SSA), excluding a healthcare innovation award; the Shared Savings Program under Section 1899 of the SSA; or a demonstration under Section 1866 of the SSA, or a demonstration required by federal law.
  • Additionally, the APM must: (1) require participants to use certified electronic health record technology (CEHRT), (2) provide for payment for covered professional services based on quality measures comparable to those in the quality performance category under MIPS, and (3) either require that participating entities bear risk for monetary losses of more than a nominal amount under the APM, or be a Medical Home Model expanded under Section 1115A(c) of the SSA.

CMS is finalizing an initial set of Advanced APM determinations that will be released no later than January 1, 2017. CMS has already indicated the following APMs will qualify as Advanced APMs for CY 2017.

  • Comprehensive ESRD Care Model (Large Dialysis Organization (LDO) arrangement)
  • Comprehensive ESRD Care Model (non-LDO arrangement)
  • Comprehensive Primary Care Plus (CPC+)
  • Medicare Shared Savings Program ACOs - Track 2
  • Medicare Shared Savings Program ACOs - Track 3
  • Next Generation ACO Model
  • Oncology Care Model (two-sided risk arrangement)

CMS intends to change and grow this list as more APMs are proposed and developed in partnership with the clinician community and the Physician-Focused Payment Model Technical Advisory Committee. The agency anticipates (but has not formally confirmed) that the following APMs will qualify as Advanced APMs in CY 2018:

The final rule sets thresholds for the level of participation in Advanced APMs required for a Qualifying APM Participant (QP) for a year. Notably, the rule gives clinicians some credit for participation in non-Medicare APMs. CMS estimates that 5 to 8 percent of eligible clinicians will qualify for participation in Advanced APMs in CY 2017.

Option 2: MIPS

MIPS is the default pathway for eligible clinicians. CMS estimates that between 592,000 and 642,000 eligible clinicians will be required to participate in MIPS in CY 2017. But the agency anticipates that over time, an increasing number of clinicians will transition from MIPS into the Advanced APM pathway. Under MIPS, clinicians will receive payment adjustments based on data submitted in four categories: quality, improvement activities, advancing care information and cost. While the improvement activities category is new, the other categories contain elements of the legacy PQRS, VM and Meaningful Use programs.

While CY 2017 marks the first MIPS performance year, payments will not be impacted until CY 2019.

Physicians will receive a MIPS score of 1 to 100 and will be paid based on an adjusted scale. In calculating the score, CMS has weighted the categories. Notably, the cost metric will be phased in over time and is weighted at zero for the CY 2017 transition year.

Additionally, MIPS phases in both negative and positive payment adjustments over time.

CMS intends that MIPS negative and positive payment adjustments will be equally distributed to ensure budget neutrality and estimates each of the adjustments will be $199 million when payments are first made in 2019. Additionally, CMS will pay $500 million for exceptional performance payments to eligible clinicians whose MIPS score is at least 70.

Picking a Pace

Recognizing the complexity of the Quality Payment Program and the tight implementation timeline, CMS introduced a "Pick Your Pace" option for eligible clinicians under the MIPS that decreases the reporting timeframe and scope of data.

  • Minimum Reporting. To avoid the negative 4 percent payment adjustment, in CY 2017 clinicians can report one measure in the quality performance category; one activity in the improvement activities performance category; or report the required measures of the advancing care coordination performance category.
  • Medium Reporting for Part of CY. Clinicians can report for less than the full CY but at least a full 90-day period on more than one quality measure, improvement activity or required measure in the advancing care information performance category to both avoid the negative 4 percent payment adjustment and possibly receive a positive MIPS payment adjustment.
  • Full Reporting for Partial or Entire CY. Clinicians can fully report to MIPS for a 90-day performance period or the entire CY to avoid the negative 4 percent payment adjustment and enhance the possibility for positive MIPS payment adjustments.

Preparing for the Long Haul

Success under the Quality Payment Program will involve changes to technology, infrastructure, physician support systems and clinical practices. CMS is providing $100 million over the next five years in technical assistance to MIPS-eligible clinicians in small practices, rural areas and practices located in geographic health professional shortage areas (HPSAs) and is evaluating the impact of MACRA on solo and small physician practices.

Eligible clinicians, even those familiar with the legacy reporting programs, must adapt to a whole new system of reporting and scoring. The MACRA rule further incentivizes these clinicians to examine their readiness to participate in APMs and weigh potential incentives against possible downside risk.

To prepare for the impending Part B reform, hospitals and physician groups should evaluate their current employment and professional services arrangements to ensure incentives and practice patterns are aligned with rewards under the Quality Payment Program. And as eligible clinicians adapt to these changes, an examination of reimbursement under fee-for-service commercial contracts (that may reward volume) will be warranted to ensure clinicians are rewarded for achievements in delivering quality accountable care.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.